Thomas Charles Reilly Cara Therapeutics, Inc. (CARA) insider trading activity

Thomas Charles Reilly is Chief Financial Officer of Cara Therapeutics, Inc.. Currently has a direct ownership of 37,811 shares of CARA, which is worth approximately $15,880. The most recent transaction as insider was on Mar 03, 2022, when has been sold 2,044 shares (Common Stock) at a price of $11.38 per share, resulting in proceeds of $23,261. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.8K

0% 3M change

0% 12M change

Total Value Held $15,880

Thomas Charles Reilly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 03 2022	SELL Open market or private sale	$23,261 $11.38 p/Share	2,044 Reduced 5.13%	37,811 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	$54,877 $10.29 p/Share	5,333 Added 11.8%	39,855 Common Stock
Feb 25 2022	BUY Grant, award, or other acquisition	-	20,000 Added 36.68%	34,522 Common Stock
Dec 17 2021	BUY Grant, award, or other acquisition	-	11,170 Added 43.48%	14,522 Common Stock
Aug 30 2021	SELL Open market or private sale	$28,144 $14.2 p/Share	1,982 Reduced 37.16%	3,352 Common Stock
Aug 24 2021	BUY Grant, award, or other acquisition	-	5,334 Added 50.0%	5,334 Common Stock

Also insider at

AMRN

AMARIN CORP PLCUK Healthcare

EVP and CFO

TCR